User contributions
Jump to navigation
Jump to search
- 01:36, 2 May 2024 diff hist -2 Main Page current
- 01:34, 2 May 2024 diff hist -36 Main Page
- 12:55, 20 April 2024 diff hist +3 m Head and neck cancer Text replacement - "Reported efficacy based" to "Reported efficacy is based"
- 12:54, 20 April 2024 diff hist +3 m Peripheral T-cell lymphoma Text replacement - "Reported efficacy based" to "Reported efficacy is based"
- 17:14, 16 April 2024 diff hist -1 m ASCO guidelines Text replacement - "old-prod.asco.org" to "society.asco.org"
- 20:16, 15 April 2024 diff hist 0 Classical Hodgkin lymphoma, pediatric
- 20:07, 15 April 2024 diff hist -1 Hepatoblastoma current
- 20:04, 15 April 2024 diff hist -29 Rhabdomyosarcoma, pediatric →Low Risk current
- 20:03, 15 April 2024 diff hist +17 Rhabdomyosarcoma, pediatric →Intermediate Risk
- 20:01, 15 April 2024 diff hist -16 Gestational trophoblastic neoplasia current
- 19:59, 15 April 2024 diff hist 0 Rhabdomyosarcoma, pediatric - historical current
- 19:57, 15 April 2024 diff hist +17 Rhabdomyosarcoma, pediatric →High Risk
- 19:57, 15 April 2024 diff hist +18 Neuroblastoma - historical →High Risk current
- 12:19, 3 April 2024 diff hist 0 m Breast cancer, HER2-positive Text replacement - "PRO Analysis:" to "PRO analysis:"
- 12:17, 3 April 2024 diff hist 0 m Light-chain (AL) amyloidosis Text replacement - "HRQoL Analysis:" to "HRQoL analysis:"
- 23:43, 27 March 2024 diff hist +994 Editorial Board current
- 23:31, 27 March 2024 diff hist -285 Editorial board transclusions →Plasma cell dyscrasia current
- 00:42, 27 March 2024 diff hist 0 m Testicular cancer Text replacement - "cycles, given" to "cycles; given"
- 00:42, 27 March 2024 diff hist 0 m Multiple myeloma - historical Text replacement - "cycles, given" to "cycles; given"
- 00:42, 27 March 2024 diff hist 0 m Multiple myeloma, induction Text replacement - "cycles, given" to "cycles; given"
- 00:42, 27 March 2024 diff hist 0 m Light-chain (AL) amyloidosis Text replacement - "cycles, "given" to "cycles; "given"
- 00:41, 27 March 2024 diff hist 0 m Diffuse large B-cell lymphoma - historical Text replacement - ", next cycle to start" to "; next cycle to start"
- 00:40, 27 March 2024 diff hist 0 m Anaplastic large cell lymphoma Text replacement - ", next cycle to start" to "; next cycle to start" current
- 00:39, 27 March 2024 diff hist -1 m Hepatoblastoma Text replacement - "21-day course (to be given within 42 days of resection)" to "21-day course; to be given within 42 days of resection"
- 00:38, 27 March 2024 diff hist +10 m Classical Hodgkin lymphoma Text replacement - "21- to 28-day cycles (depending on degree of myelosuppression)" to "21- to 28-day cycles; cycle length depends on degree of myelosuppression"
- 00:37, 27 March 2024 diff hist 0 m Colorectal cancer Text replacement - "14-day cycle for up to 6 cycles, then proceed to sLV5FU2:" to "14-day cycle for up to 6 cycles; then proceed to sLV5FU2:"
- 00:27, 27 March 2024 diff hist -32 m Acute promyelocytic leukemia Text replacement - "One course of up to 90 days" to "Up to 90-day course"
- 00:27, 27 March 2024 diff hist -8 m Acute promyelocytic leukemia Text replacement - "One course of up to 60 days" to "Up to 60-day course"
- 11:29, 26 March 2024 diff hist 0 m Colon cancer - historical Text replacement - "14-day cycle for 12 cycles, to start within 10 weeks of surgery" to "14-day cycle for 12 cycles; to start within 10 weeks of surgery" current
- 11:28, 26 March 2024 diff hist 0 m Rhabdomyosarcoma, pediatric - historical Text replacement - "12-week cycle for 4 cycles, beginning on weeks 0, 12, 24, 36" to "12-week cycle for 4 cycles; beginning on weeks 0, 12, 24, 36"
- 11:08, 13 March 2024 diff hist -9 Multiple myeloma, relapsed-refractory →Glucocorticoid therapy
- 13:59, 4 March 2024 diff hist 0 Editorial Board
- 13:30, 4 March 2024 diff hist +42 Main Page
- 13:52, 1 March 2024 diff hist +3 Pancreatic cancer
- 13:51, 1 March 2024 diff hist 0 Glioblastoma
- 13:51, 1 March 2024 diff hist +3 Esophageal cancer
- 13:50, 1 March 2024 diff hist 0 Esophageal adenocarcinoma
- 13:50, 1 March 2024 diff hist 0 Classical Hodgkin lymphoma, pediatric
- 13:50, 1 March 2024 diff hist -2 Allogeneic HSCT
- 13:35, 1 March 2024 diff hist +3 m Low-grade glioma - null regimens Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +3 m Mantle cell lymphoma Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +3 m High-grade glioma, pediatric Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +18 m Small cell lung cancer Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +6 m Glioblastoma Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +3 m Gallbladder cancer Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +3 m Pancreatic cancer Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +3 m CNS leukemia Text replacement - "4 Gy" to "400 cGy"
- 13:35, 1 March 2024 diff hist +9 m Follicular lymphoma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +3 m Cholangiocarcinoma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +27 m Classical Hodgkin lymphoma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +39 m Bladder cancer Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +15 m Esophageal cancer Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +3 m B-cell acute lymphoblastic leukemia Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +6 m Nasopharyngeal carcinoma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +18 m Head and neck cancer Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +3 m Burkitt lymphoma Text replacement - "4 Gy" to "400 cGy" current
- 13:34, 1 March 2024 diff hist +6 m Low-grade glioma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +3 m Esophageal squamous cell carcinoma Text replacement - "4 Gy" to "400 cGy"
- 13:34, 1 March 2024 diff hist +3 m Non-small cell lung cancer Text replacement - "4 Gy" to "400 cGy"
- 13:13, 1 March 2024 diff hist +36 m Cervical cancer Text replacement - "5 Gy" to "500 cGy"
- 13:13, 1 March 2024 diff hist +3 m Prostate cancer Text replacement - "5 Gy" to "500 cGy"
- 13:13, 1 March 2024 diff hist +6 m Small cell lung cancer - historical Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +24 m Esophageal cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +6 m Head and neck cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +9 m Bladder cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +18 m Non-small cell lung cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +6 m Gastric cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +3 m Follicular lymphoma Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +6 m Esophageal squamous cell carcinoma Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +15 m Pancreatic cancer Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +6 m Ewing sarcoma Text replacement - "5 Gy" to "500 cGy"
- 13:12, 1 March 2024 diff hist +12 m Anal cancer Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +21 m Anaplastic glioma Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +3 m CNS leukemia Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +57 m Rectal cancer Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +21 m Esophageal adenocarcinoma Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +6 m Rhabdomyosarcoma, pediatric - historical Text replacement - "5 Gy" to "500 cGy"
- 13:11, 1 March 2024 diff hist +6 m Anaplastic glioma - null regimens Text replacement - "5 Gy" to "500 cGy" current
- 13:10, 1 March 2024 diff hist +12 m Classical Hodgkin lymphoma Text replacement - "5 Gy" to "500 cGy"
- 13:10, 1 March 2024 diff hist +33 m Small cell lung cancer Text replacement - "5 Gy" to "500 cGy"
- 13:10, 1 March 2024 diff hist +9 m Diffuse large B-cell lymphoma Text replacement - "5 Gy" to "500 cGy"
- 13:10, 1 March 2024 diff hist +18 m CNS lymphoma Text replacement - "5 Gy" to "500 cGy"
- 13:10, 1 March 2024 diff hist +3 m Complex multipart regimens Text replacement - "5 Gy" to "500 cGy" current
- 13:10, 1 March 2024 diff hist +12 m Editing test page Text replacement - "5 Gy" to "500 cGy"
- 13:09, 1 March 2024 diff hist +6 m Classical Hodgkin lymphoma - null regimens Text replacement - "6 Gy" to "600 cGy"
- 13:09, 1 March 2024 diff hist +6 m Medulloblastoma - historical Text replacement - "6 Gy" to "600 cGy"
- 13:08, 1 March 2024 diff hist +3 m Non-small cell lung cancer - null regimens Text replacement - "6 Gy" to "600 cGy"
- 13:08, 1 March 2024 diff hist +3 m Non-small cell lung cancer, nonsquamous Text replacement - "6 Gy" to "600 cGy"
- 13:08, 1 March 2024 diff hist +60 m Classical Hodgkin lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:08, 1 March 2024 diff hist +6 m Extranodal NK- and T-cell lymphoma, nasal type Text replacement - "6 Gy" to "600 cGy" current
- 13:08, 1 March 2024 diff hist 0 m Small cell lung cancer Text replacement - ".66 Gy" to "66 cGy"
- 13:08, 1 March 2024 diff hist +6 m Cervical cancer Text replacement - "9 Gy" to "900 cGy"
- 13:07, 1 March 2024 diff hist +21 m Non-small cell lung cancer Text replacement - "6 Gy" to "600 cGy"
- 13:07, 1 March 2024 diff hist +15 m Esophageal cancer Text replacement - "6 Gy" to "600 cGy"
- 13:07, 1 March 2024 diff hist +3 m Esophageal squamous cell carcinoma Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +12 m HIV-associated lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +6 m Anaplastic large cell lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +12 m Prostate cancer Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +3 m Pancreatic cancer Text replacement - "9 Gy" to "900 cGy"
- 13:06, 1 March 2024 diff hist +3 m Esophageal cancer Text replacement - "9 Gy" to "900 cGy"
- 13:06, 1 March 2024 diff hist +3 m Non-small cell lung cancer - historical Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +3 m Allogeneic HSCT Text replacement - "9 Gy" to "900 cGy"
- 13:06, 1 March 2024 diff hist +21 m Head and neck cancer Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +24 m CNS lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +3 m Diffuse large B-cell lymphoma Text replacement - "9 Gy" to "900 cGy"
- 13:06, 1 March 2024 diff hist +9 m Anaplastic glioma Text replacement - "9 Gy" to "900 cGy"
- 13:06, 1 March 2024 diff hist +9 m Bladder cancer Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +15 m Diffuse large B-cell lymphoma - historical Text replacement - "6 Gy" to "600 cGy"
- 13:06, 1 March 2024 diff hist +12 m CNS lymphoma Text replacement - "9 Gy" to "900 cGy"
- 13:05, 1 March 2024 diff hist 0 m Esophageal cancer Text replacement - ".33 Gy" to "33 cGy"
- 13:05, 1 March 2024 diff hist +3 m Example orders for CHOEP in lymphoma Text replacement - "6 Gy" to "600 cGy" current
- 13:05, 1 March 2024 diff hist +3 m Follicular lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:05, 1 March 2024 diff hist +6 m Rhabdomyosarcoma, pediatric - historical Text replacement - "6 Gy" to "600 cGy"
- 13:05, 1 March 2024 diff hist +18 m Diffuse large B-cell lymphoma Text replacement - "6 Gy" to "600 cGy"
- 13:05, 1 March 2024 diff hist +9 m Medulloblastoma Text replacement - "6 Gy" to "600 cGy"
- 13:05, 1 March 2024 diff hist +6 m Nasopharyngeal carcinoma Text replacement - "6 Gy" to "600 cGy"
- 13:04, 1 March 2024 diff hist 0 m Anaplastic glioma Text replacement - ".25 Gy" to "25 cGy"
- 13:04, 1 March 2024 diff hist 0 m Anal cancer Text replacement - ".25 Gy" to "25 cGy"
- 13:04, 1 March 2024 diff hist +3 m Bladder cancer Text replacement - "3 Gy" to "300 cGy"
- 13:04, 1 March 2024 diff hist +12 m Non-small cell lung cancer Text replacement - "3 Gy" to "300 cGy"
- 13:03, 1 March 2024 diff hist +3 m Multiple myeloma - historical Text replacement - "3 Gy" to "300 cGy"
- 13:03, 1 March 2024 diff hist +6 m Small cell lung cancer - historical Text replacement - "3 Gy" to "300 cGy"
- 12:38, 1 March 2024 diff hist +27 m Rectal cancer Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +12 m Head and neck cancer - historical Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +9 m Glioblastoma Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +3 m Esophageal adenocarcinoma Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +36 m Non-small cell lung cancer Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +9 m Classical Hodgkin lymphoma Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +9 m Esophageal squamous cell carcinoma Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +6 m Diffuse large B-cell lymphoma Text replacement - "2 Gy" to "200 cGy"
- 12:37, 1 March 2024 diff hist +6 m Oropharyngeal cancer, HPV-positive Text replacement - "2 Gy" to "200 cGy" current
- 12:37, 1 March 2024 diff hist +3 m Pancreatic cancer Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +3 m Non-small cell lung cancer, nonsquamous Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +12 m Prostate cancer Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +3 m Mantle cell lymphoma Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +6 m Small cell lung cancer Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +3 m Small cell lung cancer - historical Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +21 m Allogeneic HSCT Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +6 m Cervical cancer Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +3 m HIV-associated lymphoma Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +6 m Extranodal NK- and T-cell lymphoma, nasal type Text replacement - "2 Gy" to "200 cGy"
- 12:36, 1 March 2024 diff hist +18 m Nasopharyngeal carcinoma Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +33 m Esophageal cancer Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +15 m Multiple myeloma - historical Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +6 m Autologous HSCT Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +21 m Bladder cancer Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +6 m Anaplastic glioma Text replacement - "2 Gy" to "200 cGy"
- 12:35, 1 March 2024 diff hist +90 m Head and neck cancer Text replacement - "2 Gy" to "200 cGy"
- 00:56, 1 March 2024 diff hist +9 m Head and neck cancer - historical Text replacement - "8 Gy" to "800 cGy"
- 00:55, 1 March 2024 diff hist +9 m CNS leukemia Text replacement - "8 Gy" to "800 cGy"
- 00:55, 1 March 2024 diff hist +3 m Bladder cancer Text replacement - "8 Gy" to "800 cGy"
- 00:55, 1 March 2024 diff hist 0 m Glioblastoma Text replacement - ".05 Gy" to "05 cGy"
- 00:54, 1 March 2024 diff hist +6 m Non-small cell lung cancer Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +9 m Prostate cancer Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +3 m Head and neck cancer Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +3 m Multiple myeloma, consolidation and maintenance Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +3 m Allogeneic HSCT Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +12 m Multiple myeloma - historical Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +6 m Medulloblastoma - historical Text replacement - "8 Gy" to "800 cGy"
- 00:54, 1 March 2024 diff hist +6 m B-cell acute lymphoblastic leukemia Text replacement - "8 Gy" to "800 cGy"
- 00:53, 1 March 2024 diff hist +3 m HemOnc vocabulary concepts Text replacement - "7 Gy" to "700 cGy" current
- 00:53, 1 March 2024 diff hist +3 m Head and neck cancer Text replacement - "7 Gy" to "700 cGy"
- 00:50, 1 March 2024 diff hist -4 m Esophageal cancer Text replacement - ".000 cGy" to "00 cGy"
- 00:50, 1 March 2024 diff hist -2 m Esophageal squamous cell carcinoma Text replacement - ".000 cGy" to "00 cGy"
- 00:50, 1 March 2024 diff hist +17 m Rectal cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:50, 1 March 2024 diff hist -1 Head and neck cancer →Radiotherapy
- 00:50, 1 March 2024 diff hist +7 m Cervical cancer Text replacement - ".7 Gy" to "70 cGy"
- 00:50, 1 March 2024 diff hist +1 m CNS lymphoma Text replacement - ".6 Gy" to "60 cGy"
- 00:49, 1 March 2024 diff hist +16 m Pancreatic cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:49, 1 March 2024 diff hist +2 m Head and neck cancer - historical Text replacement - ".4 Gy" to "40 cGy"
- 00:49, 1 March 2024 diff hist +2 m Glioblastoma Text replacement - ".4 Gy" to "40 cGy"
- 00:49, 1 March 2024 diff hist +3 m Medulloblastoma Text replacement - ".6 Gy" to "60 cGy"
- 00:49, 1 March 2024 diff hist +2 m Esophageal squamous cell carcinoma Text replacement - ".4 Gy" to "40 cGy"
- 00:49, 1 March 2024 diff hist +1 m Small cell lung cancer Text replacement - ".9 Gy" to "90 cGy"
- 00:49, 1 March 2024 diff hist +12 m Anaplastic glioma Text replacement - ".4 Gy" to "40 cGy"
- 00:49, 1 March 2024 diff hist +4 m Head and neck cancer - historical Text replacement - ".6 Gy" to "60 cGy"
- 00:49, 1 March 2024 diff hist +1 m Head and neck cancer Text replacement - ".7 Gy" to "70 cGy"
- 00:48, 1 March 2024 diff hist +4 m Rectal cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:48, 1 March 2024 diff hist +16 m Esophageal cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:48, 1 March 2024 diff hist +12 m Bladder cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:48, 1 March 2024 diff hist +4 m Medulloblastoma Text replacement - ".4 Gy" to "40 cGy"
- 00:48, 1 March 2024 diff hist +2 m Ewing sarcoma Text replacement - ".4 Gy" to "40 cGy"
- 00:48, 1 March 2024 diff hist +3 m Classical Hodgkin lymphoma Text replacement - ".6 Gy" to "60 cGy"
- 00:48, 1 March 2024 diff hist +1 m Endometrial cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:48, 1 March 2024 diff hist +1 m Vulvar cancer Text replacement - ".6 Gy" to "60 cGy" current
- 00:48, 1 March 2024 diff hist +2 m Medulloblastoma - historical Text replacement - ".6 Gy" to "60 cGy"
- 00:48, 1 March 2024 diff hist +7 m Head and neck cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:47, 1 March 2024 diff hist +2 m Non-small cell lung cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:47, 1 March 2024 diff hist +1 m Nasopharyngeal carcinoma Text replacement - ".4 Gy" to "40 cGy"
- 00:47, 1 March 2024 diff hist +1 m Esophageal cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:47, 1 March 2024 diff hist +1 m Non-small cell lung cancer - historical Text replacement - ".4 Gy" to "40 cGy"
- 00:47, 1 March 2024 diff hist +2 m Neuroblastoma Text replacement - ".6 Gy" to "60 cGy"
- 00:47, 1 March 2024 diff hist +2 m Medulloblastoma - historical Text replacement - ".4 Gy" to "40 cGy"
- 00:47, 1 March 2024 diff hist +4 m Editing test page Text replacement - ".7 Gy" to "70 cGy"
- 00:47, 1 March 2024 diff hist +2 m Anal cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:46, 1 March 2024 diff hist +1 m Cervical cancer Text replacement - ".6 Gy" to "60 cGy"
- 00:46, 1 March 2024 diff hist +3 m Editing test page Text replacement - ".4 Gy" to "40 cGy"
- 00:46, 1 March 2024 diff hist +3 m Cholangiocarcinoma Text replacement - ".4 Gy" to "40 cGy"
- 00:46, 1 March 2024 diff hist +1 m Anaplastic glioma - null regimens Text replacement - ".4 Gy" to "40 cGy"
- 00:46, 1 March 2024 diff hist +2 m Head and neck cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:45, 1 March 2024 diff hist +2 m CNS lymphoma Text replacement - ".4 Gy" to "40 cGy"
- 00:45, 1 March 2024 diff hist +4 m Cervical cancer Text replacement - ".4 Gy" to "40 cGy"
- 00:45, 1 March 2024 diff hist +2 m Extranodal NK- and T-cell lymphoma, nasal type Text replacement - ".4 Gy" to "40 cGy"
- 00:45, 1 March 2024 diff hist +1 m Cervical cancer Text replacement - ".3 Gy" to "30 cGy"
- 00:45, 1 March 2024 diff hist +17 m Bladder cancer Text replacement - ".3 Gy" to "30 cGy"
- 00:44, 1 March 2024 diff hist +6 m Non-small cell lung cancer Text replacement - "1 Gy" to "100 cGy"
- 00:44, 1 March 2024 diff hist +1 m Head and neck cancer - historical Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +4 m Head and neck cancer Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +1 m Esophageal squamous cell carcinoma Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +1 m Allogeneic HSCT Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +1 m Bladder cancer Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +1 m CNS lymphoma Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +4 m Cervical cancer Text replacement - ".2 Gy" to "20 cGy"
- 00:44, 1 March 2024 diff hist +6 m Editing test page Text replacement - "1 Gy" to "100 cGy"
- 00:44, 1 March 2024 diff hist +3 m Classical Hodgkin lymphoma, pediatric Text replacement - "1 Gy" to "100 cGy"
- 00:43, 1 March 2024 diff hist +6 m CNS lymphoma Text replacement - "1 Gy" to "100 cGy"
- 00:43, 1 March 2024 diff hist +18 m Cervical cancer Text replacement - "1 Gy" to "100 cGy"
- 00:43, 1 March 2024 diff hist +9 m Classical Hodgkin lymphoma, pediatric - historical Text replacement - "1 Gy" to "100 cGy"
- 00:34, 1 March 2024 diff hist +10 m Editing test page Text replacement - ".8 Gy" to "80 cGy"
- 00:34, 1 March 2024 diff hist +18 m Anaplastic glioma Text replacement - "0 Gy" to "000 cGy"
- 00:34, 1 March 2024 diff hist +1 m Head and neck cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:34, 1 March 2024 diff hist +1 m Cholangiocarcinoma Text replacement - ".8 Gy" to "80 cGy"
- 00:34, 1 March 2024 diff hist +27 m Small cell lung cancer Text replacement - "0 Gy" to "000 cGy"
- 00:34, 1 March 2024 diff hist +12 m Esophageal squamous cell carcinoma Text replacement - "0 Gy" to "000 cGy"
- 00:34, 1 March 2024 diff hist +3 m Anaplastic glioma - null regimens Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +30 m Diffuse large B-cell lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +12 m Bladder cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:33, 1 March 2024 diff hist +6 m Autologous HSCT Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +6 m Non-small cell lung cancer, CNS metastases Text replacement - "0 Gy" to "000 cGy" current
- 00:33, 1 March 2024 diff hist +1 m Non-small cell lung cancer - historical Text replacement - ".8 Gy" to "80 cGy"
- 00:33, 1 March 2024 diff hist +12 m Medulloblastoma Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +30 m Glioblastoma Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +6 m Thymoma Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +1 m Endometrial cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:33, 1 March 2024 diff hist +69 m CNS lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:33, 1 March 2024 diff hist +18 m Rectal cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:33, 1 March 2024 diff hist +1 m Peripheral T-cell lymphoma Text replacement - ".8 Gy" to "80 cGy"
- 00:33, 1 March 2024 diff hist +1 m Small cell lung cancer - historical Text replacement - ".8 Gy" to "80 cGy"
- 00:32, 1 March 2024 diff hist +1 m Allogeneic HSCT Text replacement - ".5 Gy" to "50 cGy"
- 00:32, 1 March 2024 diff hist +1 m CNS lymphoma Text replacement - ".8 Gy" to "80 cGy"
- 00:32, 1 March 2024 diff hist +1 m Autologous HSCT Text replacement - ".5 Gy" to "50 cGy"
- 00:32, 1 March 2024 diff hist +3 m Endometrial cancer Text replacement - "0 Gy" to "000 cGy"
- 00:31, 1 March 2024 diff hist +6 m Peripheral T-cell lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:31, 1 March 2024 diff hist +2 m Prostate cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:31, 1 March 2024 diff hist +6 m Testicular cancer Text replacement - "0 Gy" to "000 cGy"
- 00:31, 1 March 2024 diff hist +9 m Classical Hodgkin lymphoma - null regimens Text replacement - "0 Gy" to "000 cGy"
- 00:31, 1 March 2024 diff hist +3 m Head and neck cancer - historical Text replacement - ".8 Gy" to "80 cGy"
- 00:30, 1 March 2024 diff hist +6 m Ewing sarcoma Text replacement - "0 Gy" to "000 cGy"
- 00:30, 1 March 2024 diff hist +18 m Esophageal cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:30, 1 March 2024 diff hist +6 m Primary mediastinal B-cell lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:30, 1 March 2024 diff hist +1 m Esophageal cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:30, 1 March 2024 diff hist +6 m Esophageal adenocarcinoma Text replacement - ".8 Gy" to "80 cGy"
- 00:30, 1 March 2024 diff hist +9 m Extranodal NK- and T-cell lymphoma, nasal type Text replacement - "0 Gy" to "000 cGy"
- 00:30, 1 March 2024 diff hist +6 m Head and neck cancer - historical Text replacement - "0 Gy" to "000 cGy"
- 00:29, 1 March 2024 diff hist +1 m Low-grade glioma Text replacement - ".8 Gy" to "80 cGy"
- 00:29, 1 March 2024 diff hist +66 m Head and neck cancer Text replacement - "0 Gy" to "000 cGy"
- 00:29, 1 March 2024 diff hist +27 m Prostate cancer Text replacement - "0 Gy" to "000 cGy"
- 00:29, 1 March 2024 diff hist +9 m Ewing sarcoma Text replacement - ".8 Gy" to "80 cGy"
- 00:29, 1 March 2024 diff hist +4 m Non-small cell lung cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:29, 1 March 2024 diff hist +2 m Small cell lung cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:28, 1 March 2024 diff hist +3 m Esophageal adenocarcinoma Text replacement - "0 Gy" to "000 cGy"
- 00:28, 1 March 2024 diff hist +12 m Pancreatic cancer Text replacement - "0 Gy" to "000 cGy"
- 00:28, 1 March 2024 diff hist +20 m Bladder cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:28, 1 March 2024 diff hist +1 m Cervical cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:27, 1 March 2024 diff hist +8 m Anaplastic glioma Text replacement - ".8 Gy" to "80 cGy"
- 00:27, 1 March 2024 diff hist +33 m Non-small cell lung cancer Text replacement - "0 Gy" to "000 cGy"
- 00:27, 1 March 2024 diff hist +156 m Classical Hodgkin lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:27, 1 March 2024 diff hist +1 m Gastric cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +3 m Head and neck cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +2 m Non-small cell lung cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:26, 1 March 2024 diff hist +4 m Medulloblastoma - historical Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +19 m Cervical cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +2 m Esophageal squamous cell carcinoma Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +1 m Extranodal NK- and T-cell lymphoma, nasal type Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +4 m Anal cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +6 m Medulloblastoma Text replacement - ".8 Gy" to "80 cGy"
- 00:26, 1 March 2024 diff hist +10 m Small cell lung cancer Text replacement - ".5 Gy" to "50 cGy"
- 00:25, 1 March 2024 diff hist +1 m Vulvar cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:25, 1 March 2024 diff hist +42 m Cervical cancer Text replacement - "0 Gy" to "000 cGy"
- 00:25, 1 March 2024 diff hist +7 m Pancreatic cancer Text replacement - ".8 Gy" to "80 cGy"
- 00:24, 1 March 2024 diff hist +1 m Glioblastoma Text replacement - ".8 Gy" to "80 cGy"
- 00:24, 1 March 2024 diff hist +1 m High-grade glioma, pediatric Text replacement - ".8 Gy" to "80 cGy"
- 00:24, 1 March 2024 diff hist +1 m Head and neck cancer Text replacement - ".1 Gy" to "10 cGy"
- 00:24, 1 March 2024 diff hist +1 m Head and neck cancer - historical Text replacement - ".5 Gy" to "50 cGy"
- 00:24, 1 March 2024 diff hist +4 m CNS lymphoma Text replacement - ".5 Gy" to "50 cGy"
- 00:24, 1 March 2024 diff hist +1 m Neuroblastoma Text replacement - ".5 Gy" to "50 cGy"
- 00:24, 1 March 2024 diff hist +6 m Complex multipart regimens Text replacement - "0 Gy" to "000 cGy"
- 00:24, 1 March 2024 diff hist +2 m CNS carcinoma Text replacement - ".5 Gy" to "50 cGy" current
- 00:24, 1 March 2024 diff hist +2 m Small cell lung cancer Text replacement - ".1 Gy" to "10 cGy"
- 00:24, 1 March 2024 diff hist +6 m Oropharyngeal cancer, HPV-positive Text replacement - "0 Gy" to "000 cGy"
- 00:24, 1 March 2024 diff hist +1 m HemOnc vocabulary concepts Text replacement - ".1 Gy" to "10 cGy"
- 00:23, 1 March 2024 diff hist +6 m Non-small cell lung cancer - null regimens Text replacement - "0 Gy" to "000 cGy"
- 00:23, 1 March 2024 diff hist +3 m Small cell lung cancer - historical Text replacement - "0 Gy" to "000 cGy"
- 00:23, 1 March 2024 diff hist +3 m Diffuse large B-cell lymphoma - historical Text replacement - "0 Gy" to "000 cGy"
- 00:23, 1 March 2024 diff hist +3 m Hepatocellular carcinoma Text replacement - "0 Gy" to "000 cGy"
- 00:23, 1 March 2024 diff hist +3 m Glioblastoma - null regimens Text replacement - "0 Gy" to "000 cGy" current
- 00:23, 1 March 2024 diff hist +9 m Classical Hodgkin lymphoma - historical Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +9 m Allogeneic HSCT Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +9 m HIV-associated lymphoma Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +18 m Bladder cancer Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +18 m Nasopharyngeal carcinoma Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +48 m Esophageal cancer Text replacement - "0 Gy" to "000 cGy"
- 00:22, 1 March 2024 diff hist +33 m Rectal cancer Text replacement - "0 Gy" to "000 cGy"
- 23:55, 29 February 2024 diff hist 0 Main Page
- 18:30, 28 February 2024 diff hist -2 Non-small cell lung cancer, squamous →Carboplatin & Gemcitabine (GCb) {{#subobject:geww8q|Regimen=1}}
- 11:17, 26 February 2024 diff hist +1 m Urothelial carcinoma Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)"
- 11:17, 26 February 2024 diff hist +1 m Toripalimab (Tuoyi) Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)" current Tag: Redirect target changed
- 11:16, 26 February 2024 diff hist +1 m Esophageal squamous cell carcinoma Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)"
- 11:16, 26 February 2024 diff hist +1 m Toripalimab (JS001) Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)" current Tag: Redirect target changed
- 11:16, 26 February 2024 diff hist +2 m Nasopharyngeal carcinoma Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)"
- 11:16, 26 February 2024 diff hist +1 m Melanoma Text replacement - "Toripalimab (Loqtorz)" to "Toripalimab (Loqtorzi)"
- 18:46, 7 February 2024 diff hist +26 User:Seemanagpal current
- 18:44, 7 February 2024 diff hist +3 Editorial Board
- 18:14, 7 February 2024 diff hist 0 File:HemOnc SOP QA.pdf Warner-admin uploaded a new version of File:20211027 HemOnc SOP QA.pdf
- 02:10, 1 February 2024 diff hist -112 m Melanoma - null regimens Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_"
- 02:10, 1 February 2024 diff hist -28 m Colon cancer - historical Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_"
- 02:10, 1 February 2024 diff hist -56 m Bladder cancer Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_"
- 02:10, 1 February 2024 diff hist -28 m Non-small cell lung cancer - null regimens Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_"
- 02:10, 1 February 2024 diff hist -56 m Colon cancer - null regimens Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_" current
- 02:10, 1 February 2024 diff hist -28 m Classical Hodgkin lymphoma - null regimens Text replacement - "#Bacillus_Calmette-Gu.C3.A9rin_.28BCG.29_" to "#BCG_vaccine_"
- 14:00, 30 January 2024 diff hist 0 m Light-chain (AL) amyloidosis Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 14:00, 30 January 2024 diff hist 0 m Acute myeloid leukemia Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 14:00, 30 January 2024 diff hist 0 m Follicular lymphoma Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 14:00, 30 January 2024 diff hist 0 m Multiple myeloma, consolidation and maintenance Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 14:00, 30 January 2024 diff hist 0 m Breast cancer - null regimens Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 13:59, 30 January 2024 diff hist 0 m Diffuse large B-cell lymphoma Text replacement - "primary composite endpoint" to "composite primary endpoint"
- 13:55, 22 January 2024 diff hist +226 Tutorial
- 21:27, 16 January 2024 diff hist 0 m Main Page
- 19:07, 16 January 2024 diff hist 0 Editorial Board
- 13:45, 16 January 2024 diff hist +35 Regimen naming conventions (nomenclature) →Regimens with Substitutions
- 13:45, 16 January 2024 diff hist +167 Regimen naming conventions (nomenclature)
- 14:23, 2 January 2024 diff hist +120 Eligibility criteria →Experimental arm(s)
- 03:44, 2 January 2024 diff hist +1 Editorial Board
- 03:43, 2 January 2024 diff hist +1 Main Page
- 16:12, 1 January 2024 diff hist -21 Eligibility criteria →Prioritization
- 16:10, 1 January 2024 diff hist -32 Eligibility criteria →Screening for trials
- 16:08, 1 January 2024 diff hist -6 Eligibility criteria →Screening for trials
- 16:07, 1 January 2024 diff hist +593 Eligibility criteria →Non-randomized or retrospective studies
- 16:01, 1 January 2024 diff hist +14 Eligibility criteria →Exceptions
- 16:00, 1 January 2024 diff hist -4 Eligibility criteria →RCTs with experimental arms only
- 16:00, 1 January 2024 diff hist +407 Eligibility criteria →Experimental arm(s)
- 15:56, 1 January 2024 diff hist +73 Eligibility criteria →Defining the Standard of Care (SOC)
- 15:51, 1 January 2024 diff hist +411 Eligibility criteria →Defining the Standard of Care (SOC)
- 15:45, 1 January 2024 diff hist +87 Eligibility criteria →Defining the Standard of Care (SOC)
- 15:42, 1 January 2024 diff hist +30 Eligibility criteria →Background
- 04:28, 31 December 2023 diff hist -20 m Autologous HSCT Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 04:28, 31 December 2023 diff hist -20 m T-cell acute lymphoblastic leukemia Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 04:28, 31 December 2023 diff hist -120 m B-cell acute lymphoblastic leukemia Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 04:28, 31 December 2023 diff hist -40 m B-cell acute lymphoblastic leukemia, Ph-positive Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 04:27, 31 December 2023 diff hist -20 m Allogeneic HSCT Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 04:27, 31 December 2023 diff hist -40 m CNS leukemia Text replacement - "http://www.bloodjournal.org/content/106/12/3760.long" to "https://doi.org/10.1182/blood-2005-04-1623"
- 14:38, 30 December 2023 diff hist -1 m Hepatocellular carcinoma Text replacement - "_8888" to "_333"
- 14:38, 30 December 2023 diff hist -1 m Breast cancer - null regimens Text replacement - "_8888" to "_333"
- 14:38, 30 December 2023 diff hist -1 m Cholangiocarcinoma Text replacement - "_8888" to "_333"
- 14:38, 30 December 2023 diff hist -1 m Gallbladder cancer Text replacement - "_8888" to "_333"
- 14:37, 30 December 2023 diff hist -1 m Non-small cell lung cancer, nonsquamous Text replacement - "_8888" to "_333"
- 14:37, 30 December 2023 diff hist -1 m Gastric cancer Text replacement - "_8888" to "_333"
- 14:37, 30 December 2023 diff hist -1 m Gastric cancer - null regimens Text replacement - "_8888" to "_333"
- 14:37, 30 December 2023 diff hist -1 m Breast cancer, HER2-positive - null regimens Text replacement - "_8888" to "_333"
- 14:25, 30 December 2023 diff hist +210 Value frameworks
- 14:24, 30 December 2023 diff hist +210 Levels of Evidence current
- 14:24, 30 December 2023 diff hist +207 Ontology current
- 14:22, 30 December 2023 diff hist +201 Tutorial
- 14:06, 30 December 2023 diff hist +1 Tutorial →Preliminary results
- 14:02, 30 December 2023 diff hist +2 Tutorial →Alphabetical list of drugs
- 14:00, 30 December 2023 diff hist +21 Tutorial →Response criteria
- 13:59, 30 December 2023 diff hist +20 Tutorial →Abstracts
- 13:57, 30 December 2023 diff hist +530 Tutorial →Parts and portions
- 13:56, 30 December 2023 diff hist +967 Tutorial →Parts and portions
- 13:55, 30 December 2023 diff hist +118 Tutorial →Multi-part regimens
- 13:45, 30 December 2023 diff hist +20 Tutorial →Dose modifications
- 14:58, 27 December 2023 diff hist +16 m Chronic lymphocytic leukemia Text replacement - "cycle up" to "cycle for up"
- 14:58, 27 December 2023 diff hist +8 m Mantle cell lymphoma Text replacement - "cycle up" to "cycle for up"
- 14:58, 27 December 2023 diff hist +4 m Follicular lymphoma - historical Text replacement - "cycle up" to "cycle for up"
- 14:57, 27 December 2023 diff hist +4 m Diffuse large B-cell lymphoma - historical Text replacement - "cycle up" to "cycle for up"
- 02:59, 25 December 2023 diff hist +5 Tutorial →Prescription details
- 02:56, 25 December 2023 diff hist +138 Tutorial →Entry criteria
- 02:55, 25 December 2023 diff hist -2 Tutorial →Comparative Toxicity
- 02:55, 25 December 2023 diff hist +1 Tutorial →Efficacy and Comparative Efficacy
- 02:54, 25 December 2023 diff hist +71 Tutorial →Comparator(s)
- 02:53, 25 December 2023 diff hist 0 Tutorial →Experimental arms that led to FDA approval
- 02:52, 25 December 2023 diff hist +8 Tutorial →Design of the experimental arm
- 02:52, 25 December 2023 diff hist +2 Tutorial →Design of the experimental arm
- 02:52, 25 December 2023 diff hist +89 Tutorial →Design of the experimental arm
- 02:51, 25 December 2023 diff hist +297 Tutorial →Regimens
- 02:45, 25 December 2023 diff hist -362 Tutorial →Regimen variants
- 02:44, 25 December 2023 diff hist -64 Tutorial →Regimen variants
- 02:39, 25 December 2023 diff hist -27 Tutorial →Regimen variants
- 02:38, 25 December 2023 diff hist +8 Tutorial →Regimen variants
- 02:37, 25 December 2023 diff hist +5 Tutorial →Regimen variants
- 02:37, 25 December 2023 diff hist +301 Tutorial →Regimen variants
- 02:34, 25 December 2023 diff hist -1 Tutorial →Example order sets
- 02:33, 25 December 2023 diff hist -1 Tutorial →Example order sets
- 02:33, 25 December 2023 diff hist -2 Tutorial →Example order sets
- 02:32, 25 December 2023 diff hist -12 Tutorial →Regimen alias(es)
- 02:31, 25 December 2023 diff hist -4 Tutorial →Regimen alias(es)
- 02:31, 25 December 2023 diff hist +20 Tutorial →Preferred name
- 02:29, 25 December 2023 diff hist +1,144 Tutorial →Anatomy of a regimen
- 02:23, 25 December 2023 diff hist +5 Tutorial →Table of contents
- 02:22, 25 December 2023 diff hist +19 Tutorial →Disease-specific regimen pages
- 02:21, 25 December 2023 diff hist -535 Tutorial →Disease-specific regimen pages
- 02:19, 25 December 2023 diff hist +46 Tutorial →Disease-specific regimen pages
- 02:18, 25 December 2023 diff hist +220 Tutorial →Disease-specific regimen pages
- 02:16, 25 December 2023 diff hist +4 Tutorial →Disease-specific regimen pages
- 02:15, 25 December 2023 diff hist +6 Tutorial →Disease-specific regimen pages
- 02:15, 25 December 2023 diff hist +5 Tutorial →Contributors
- 02:14, 25 December 2023 diff hist +68 Tutorial →Stay in touch
- 02:11, 25 December 2023 diff hist +931 Tutorial →Bottom section
- 02:10, 25 December 2023 diff hist -61 Tutorial →Top section
- 02:08, 25 December 2023 diff hist +148 Tutorial →History of changes in FDA indication
- 02:06, 25 December 2023 diff hist -163 Tutorial
- 02:04, 25 December 2023 diff hist +866 Tutorial →FAQ
- 01:55, 25 December 2023 diff hist +137 Ontology →FAQ
- 19:54, 23 December 2023 diff hist 0 m Classical Hodgkin lymphoma - historical Text replacement - "(Cycles" to "(cycles"
- 19:54, 23 December 2023 diff hist 0 m Multiple myeloma - historical Text replacement - "(Cycles" to "(cycles"
- 19:54, 23 December 2023 diff hist 0 m Small cell lung cancer Text replacement - "(Cycles" to "(cycles"
- 19:54, 23 December 2023 diff hist 0 m Small cell lung cancer - historical Text replacement - "(Cycles" to "(cycles"
- 19:19, 23 December 2023 diff hist +4 m Breast cancer, ER-positive - null regimens Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy|" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2|"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - historical Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - null regimens Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3"
- 19:18, 23 December 2023 diff hist 0 m Complex multipart regimens Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer - historical Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_2" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_4"
- 19:18, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - historical Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_3" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_4"
- 19:17, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - historical Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_4" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_5"
- 19:17, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - null regimens Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_4" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_5"
- 19:16, 23 December 2023 diff hist 0 m Breast cancer, ER-positive - historical Text replacement - "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_5" to "Breast_cancer,_ER-positive#Tamoxifen_monotherapy_6"
- 17:40, 22 December 2023 diff hist +1 m Melanoma - historical Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Follicular lymphoma Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Non-small cell lung cancer - historical Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Multiple myeloma - historical Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +4 m Esophageal cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Anaplastic glioma Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +2 m Gastric cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Chronic lymphocytic leukemia - historical Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +3 m Rectal cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +2 m Melanoma Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +1 m Head and neck cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +5 m Breast cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:40, 22 December 2023 diff hist +3 m Non-small cell lung cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:39, 22 December 2023 diff hist +1 m Pancreatic cancer Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:39, 22 December 2023 diff hist +1 m Chronic lymphocytic leukemia Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:39, 22 December 2023 diff hist +2 m Classical Hodgkin lymphoma Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:39, 22 December 2023 diff hist +2 m Multiple myeloma, relapsed-refractory Text replacement - "''Note: this is an" to "''Note: This was an"
- 17:38, 22 December 2023 diff hist +1 m Classical Hodgkin lymphoma Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Breast cancer Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +2 m Multiple myeloma, induction Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Classical Hodgkin lymphoma - historical Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Breast cancer, HER2-positive Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Multiple myeloma - historical Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Mantle cell lymphoma Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Systemic mastocytosis Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Ewing sarcoma Text replacement - "''Note: This is a" to "''Note: This was a"
- 17:37, 22 December 2023 diff hist +1 m Rectal cancer Text replacement - "''Note: This is a" to "''Note: This was a"
- 14:00, 22 December 2023 diff hist -63 Hypereosinophilic syndrome
- 13:59, 22 December 2023 diff hist -37 Cutaneous T-cell lymphoma
- 13:58, 22 December 2023 diff hist -68 Colorectal cancer - historical
- 13:57, 22 December 2023 diff hist -120 Breast cancer, HER2-positive
- 13:56, 22 December 2023 diff hist -60 m Breast cancer
- 22:32, 21 December 2023 diff hist +70 Cutaneous squamous cell carcinoma →Cetuximab monotherapy {{#subobject:5f3411|Regimen=1}}
- 20:26, 21 December 2023 diff hist +20 Trastuzumab (Herceptin) current
- 20:26, 21 December 2023 diff hist +148 Trastuzumab (Herceptin)
- 22:13, 20 December 2023 diff hist +75 Main Page
- 21:58, 20 December 2023 diff hist -37 Thiotepa (Thioplex) current
- 21:57, 20 December 2023 diff hist -38 Doxorubicin (Adriamycin) current
- 21:57, 20 December 2023 diff hist +123 Defibrotide (Defitelio)
- 21:55, 20 December 2023 diff hist -154 m Diffuse large B-cell lymphoma Text replacement - "lst:Autologous HSCT conditioning regimens" to "lst:Autologous HSCT"
- 21:55, 20 December 2023 diff hist -132 m Mantle cell lymphoma Text replacement - "lst:Autologous HSCT conditioning regimens" to "lst:Autologous HSCT"
- 21:55, 20 December 2023 diff hist -22 m Follicular lymphoma Text replacement - "lst:Autologous HSCT conditioning regimens" to "lst:Autologous HSCT"
- 21:53, 20 December 2023 diff hist -66 m High-grade B-cell lymphoma Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -22 m Mantle cell lymphoma Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -44 m B-cell acute lymphoblastic leukemia, pediatric Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -22 m Primary mediastinal B-cell lymphoma Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -88 m Diffuse large B-cell lymphoma Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -22 m Tutorial Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -66 m Transplant conditioning regimens Text replacement - "_conditioning_regimens" to "" current
- 21:53, 20 December 2023 diff hist -22 m Follicular lymphoma Text replacement - "_conditioning_regimens" to ""
- 21:53, 20 December 2023 diff hist -66 m B-cell acute lymphoblastic leukemia Text replacement - "_conditioning_regimens" to ""
- 21:52, 20 December 2023 diff hist -17 Diffuse large B-cell lymphoma - historical
- 21:52, 20 December 2023 diff hist -68 B-cell acute lymphoblastic leukemia
- 19:39, 20 December 2023 diff hist +2 m Prostate cancer Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:39, 20 December 2023 diff hist +2 m Low-grade glioma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Low-grade glioma, pediatric Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Small cell lung cancer Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Breast cancer, ER-positive Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Hodgkin lymphoma, nodular lymphocyte-predominant Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Chronic myelomonocytic leukemia Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Adult T-cell leukemia-lymphoma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Hairy cell leukemia Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m POEMS syndrome Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only." current
- 19:38, 20 December 2023 diff hist +2 m Thymoma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Light-chain (AL) amyloidosis Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Anaplastic glioma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Classical Hodgkin lymphoma, pediatric Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Gestational trophoblastic neoplasia Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Smoldering multiple myeloma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Acute promyelocytic leukemia Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m CNS lymphoma Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only."
- 19:38, 20 December 2023 diff hist +2 m Tenosynovial giant cell tumor Text replacement - "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only." to "Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only." current